Related references
Note: Only part of the references are listed.Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation
Brian De et al.
BJU INTERNATIONAL (2022)
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group
Ciro Franzese et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
G. Marvaso et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
Patrick Cheung et al.
EUROPEAN UROLOGY (2021)
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Yang Liu et al.
WORLD JOURNAL OF UROLOGY (2021)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Yuanyuan Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma
Bimal Bhindi et al.
EUROPEAN UROLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
Nicholas G. Zaorsky et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Alexander Ruhle et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group
Emmanuel Meyer et al.
EUROPEAN JOURNAL OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Skeletal metastasis in renal cell carcinoma: A review
Masood Umer et al.
ANNALS OF MEDICINE AND SURGERY (2018)
Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment
Christian P. Meyer et al.
EUROPEAN UROLOGY (2017)
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases
Chiachien Jake Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Rhinovirus is associated with severe adult community-acquired pneumonia in China
Juliane Hoerner-Rieber et al.
JOURNAL OF THORACIC DISEASE (2017)
Stereotactic body radiotherapy for oligoprogressive cancer
Patrick Cheung
BRITISH JOURNAL OF RADIOLOGY (2016)
Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)
Basel Altoos et al.
RADIATION ONCOLOGY (2015)
Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A systematic review
Gargi Kothari et al.
ACTA ONCOLOGICA (2015)
Kidney Cancer, Version 2.2014 Featured Updates to the NCCN Guidelines
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Local treatments for metastases of renal cell carcinoma: a systematic review
Saeed Dabestani et al.
LANCET ONCOLOGY (2014)
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: Phase 2 results
Samuel Ryu et al.
PRACTICAL RADIATION ONCOLOGY (2014)
International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery
Brett W. Cox et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
TUMOR CONTROL OUTCOMES AFTER HYPOFRACTIONATED AND SINGLE-DOSE STEREOTACTIC IMAGE-GUIDED INTENSITY-MODULATED RADIOTHERAPY FOR EXTRACRANIAL METASTASES FROM RENAL CELL CARCINOMA
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Outcomes and Clinicopathologic Variables Associated With Late Recurrence After Nephrectomy for Localized Renal Cell Carcinoma
Simon P. Kim et al.
UROLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
An overview of hypofractionation and introduction to this issue of Seminars in Radiation Oncology
Robert D. Timmerman
SEMINARS IN RADIATION ONCOLOGY (2008)
A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma
Christer Svedman et al.
ACTA ONCOLOGICA (2006)
Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma
PJ Wersäll et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Share Paper
